antibody, even though the states of active immunity memory in T-cell-mediated antibacterial immunity. As a first step in investigating the cellular

Size: px
Start display at page:

Download "antibody, even though the states of active immunity memory in T-cell-mediated antibacterial immunity. As a first step in investigating the cellular"

Transcription

1 INFECTION AND IMMUNITY, Oct. 1975, p Copyright ) 1975 American Society for Microbiology Vol. 12, No. 4 Printed in U.S.A. Nature of "Memory" in T-Cell-Mediated Antibacterial Immunity: Cellular Parameters That Distinguish Between the Active Immune Response and a State of "Memory" R. J. NORTH* AND J. F. DEISSLER Trudeau Institute, Inc., Saranac Lake, New York Received for publication 28 May 1975 Immunizing infection in mice with Listeria monocytogenes resulted in the generation of two distinct states of immunological reactivity. There was generated (i) a short-lived state of active immunity that functioned to urgently eliminate the infecting organism from the tissues and (ii) a long-lived state of increased immunological potential that enabled the host to respond to secondary infection in an accelerated manner. Short-lived active immunity was mediated by replicating T cells and expressed by activated macrophages, and it ended when these cell types disappeared from the tissue soon after complete elimination of the parasite. Long-lived immunological potential was associated with a persistent level of delayed sensitivity and with the presence of a small number of nonreplicating protective T cells. It is suggested that the state of delayed sensitivity represents a state of immunological T-cell memory of the cell-mediated type. It was shown in a preceding paper (14) that termination of an immunizing infection with Listeria monocytogenes in mice is followed by a state of long-lived, heightened, specific resistance to reinfection. It was also shown that the acquired resistance as expressed against lethal challenge infection was dependent on an acquired long-term capacity on the part of the immunized host to generate protective lymphocytes faster and in larger numbers than a nonimmunized host. The lymphocytes generated to combat secondary infection, moreover, were shown to be of the same class as those generated to combat primary infection. In both cases they were thymus-derived lymphocytes (T cells), many of which were replicating. It was suggested, in view of this evidence, that the enhanced production of mediator T cells that occurs in response to secondary Listeria infection represents the expression of a state of immunological memory. The expression of this form of T-cell memory as an accelerated and increased production of sensitized mediator T cells, then, is analogous to the expression of antibody or B-cell memory as an accelerated production of antibody-forming B cells. The term "immunological memory," however, implies that a state of acquired heightened reactivity to specific antigen can exist long after the active immune response has ended (4), i.e., long after the cells that mediate or effect immunity have disappeared. Indeed, it is now well established (4, 5, 7, 17) that immuno- 761 logical memory acquired during an antibody response is carried by lymphocytes that are physiologically different from those that secrete antibody, even though the states of active immunity and memory can coexist. The same conclusion, however, cannot yet be made about memory in T-cell-mediated antibacterial immunity. As a first step in investigating the cellular basis of memory in T-cell-mediated antibacterial immunity, therefore, it was necessary to obtain information showing that the state of active immunity generated to terminate a primary Listeria infection is different from the acquired state of heightened, specific resistance to reinfection that persists for a long time after the primary infecting organism is eliminated from the tissues. This paper will show that the active immune response to an intravenous Listeria infection occupies a limited period of time, during which there is increased lymphoid cell division and the generation of short-lived mediator T cells in the spleen, the generation of a state of delayed sensitivity to Listeria antigens, and the systemic activation of macrophages. It will show, in addition, that loss of replicating mediator T cells and effector macrophages results in loss of active immunity, and that this is followed by a long-lived state of heightened resistance to reinfection that is temporally associated with a persistent level of delayed sensitivity and with the retention of a small number of nonreplicating "protective" T cells.

2 762 NORTH AND DEISSLER MATERIALS AND METHODS Mice, the preparation oflisteria cultures, and the method used for estimating changes in the level of production of protective lymphocytes in the spleen were the same as described in the preceding paper (14). The methods for selectively destroying dividing protective cells in vivo with a 15-h pulse of vinblastine sulfate, and for testing the susceptibility of protective cells to incubation in vitro with AKR anti-c3h 0-serum and complement, were also the same as in the preceding paper (14). Spleen cell division. Changes in the relative number of cells dividing in the spleen were followed by measuring changes in the amount of tritiated thymidine ([3H]TdR of specific activity 3 Ci/mmol obtained from New England Nuclear Corp., Boston, Mass.) incorporated into total spleen deoxyribonucleic acid (DNA) from a single 20-pCi injection given intravenously. Spleens were removed 30 min after being given [3H]TdR, and an acid-soluble extract was prepared and counted (counts per minute per organ) by liquid scintillation spectrophotometry as described previously (10). Systemic macrophage activation. Changes in the level of systemic macrophage activation during the course of a Listeria infection were determined by measuring changes in the capacity of mice to resist a standard 105 intravenous challenge infection with the bacterium Yersinia enterocolitica (strain WA). The organism was kindly provided by P. Carter (Trudeau Institute), who has published a description of its growth characteristics in mice (3). Nonspecific resistance was expressed as log,0 resistance index. This was obtained by subtracting the 24-h growth of Yersinia in the livers of Listeria-infected mice from its 24-h growth in the livers of control mice. A resistance index of 1 means that Yersinia grew 1 log less in Listeria-infected mice. The meaning of the resistance index in terms of macrophage activation has been discussed previously (11). Antibody. Serum antibodies produced in response to Listeria infection were measured by the technique of passive hemagglutination, which employed soluble Listeria antigens coupled to sheep erythrocytes with glutaraldehyde (9). Appropriate controls were included. The test serum was compared with a positive rabbit anti-listeria serum that gave an agglutination titer of 1:4,096. The soluble Listeria protein antigens were obtained from a Listeria culture filtrate by precipitation with ammonium sulfate followed by purification by exclusion chromatography (LeGarrec and Mackaness, to be published). Delayed sensitivity. Delayed sensitivity reactions were measured in the hind footpad with dial calipers as described previously (10). Delayed reactions were elicited by an intra-footpad injection of 10 Ag of Listeria protein antigens in 0.05 ml of 0.85% sodium chloride solution and read 24 h later. The antigens were the same as those used for the hemagglutination assay. RESULTS Cellular changes that characterize the primary response, memory, and expression INFECT. IMMUN. of memory. A previous study showed (14) that an immunizing infection with Listeria results in the acquisition of a long-term state of heightened immunological potential that enables the host to respond to secondary infection with an increased rate of production of mediator lymphocytes. The following study was designed to compare the primary and secondary anti-listeria responses in terms of some additional parameters and to use the information to distinguish between these states of active immunity and the state of memory that temporarily separates them. This involved performing concurrent measurements of (i) changes against time of infection in DNA synthesis and the production of dividing and nondividing protective lymphocytes in the spleen and (ii) changes in the level of systemic delayed sensitivity as measured by 24-h footpad reactions to an injection ofsoluble Listeria antigens. In addition, the production of serum antibodies to the same antigens as those used to elicit delayed sensitivity reactions was followed by the method of passive hemagglutination. All of these parameters were followed for 50 days after initiating primary infection and for 20 days after initiating secondary infection. The results are summarized in Fig. 1 and 2. It was found (Fig. 1), as expected from a previous study (14), that lethal secondary infection was eliminated more quickly than a sublethal primary infection. Whereas the primary infection multiplied for 3 days before being progressively eliminated by days 10 to 12, the secondary infection multiplied for only 24 h and was eliminated completely by day 8. The earlier expression of immunity to secondary infection, moreover, was associated with a faster rate of production in the spleen of lymphocytes that could protect normal test recipients against lethal challenge. Thus, although production of these cells in response to primary infection peaked on day 6, a higher level of peak production occurred 2 days earlier in response to secondary infection, and this occurred in spite of a lower level of infection. Indeed, this faster rate of production of protective lymphocytes in response to secondary infection was evident by the second day of infection. Peak production of protective cells in both responses was immediately followed by a progressive decline in their number. A more rapid decline, however, occurred after peak secondary production, and this was associated with the faster rate of elimination of Listeria from the tissues. Protective lymphocytes did not completely disappear from the spleen over the course of this study. In fact, the initial progressive rapid loss of these cells that immediately followed

3 VOL. 12, 1975 ACTIVE IMMUNE RESPONSE AND "MEMORY' IN T CELLS 763 involved the production of both types of protective cells. However, whereas dividing protective cells completely disappeared 6 days after peak primary production, nondividing cells, after a limited loss, persisted in small but significant numbers for a long time thereafter. Whereas the curve for changes in the number of replicating protective cells showed a striking temporal correlation with the curve for changes in DNA synthesis, in the spleen the curve for changes in the number of nonreplicating protective cells was closely correlated with the curve for changes in the level of delayed sensitivity (Fig. 2). Thus, whereas dividing protective cells were only present in the spleen in functional numbers during the brief period of increased lymphoid cell division in this organ, nondividing protective cells and delayed sensitivity persisted for a long time in the apparent absence of increased spleen cell division. FIG. 1. Kinetics ofproduction ofprotective lymphocytes in the spleen during primary (2 x 103) and secondary (2 x 105) Listeria infection (arrows) compared with growth curves ofparasite in the liver and with the production of circulating antibodies to soluble Listeria antigens. Protective T cells were produced much faster in response to secondarily infected (4-day peak response compared to 6-day peak for primary infection), and this was temporally associated with the faster onset of expression of antibacterial immunity and the faster elimination of bacteria from the tissues. The number of protective lymphocytes rapidly declined after peak primary response, but a small number persisted until the initiation of secondary infection. No agglutinating antibodies were produced in response to primary infection, but mercaptoethanol-sensitive antibody was produced in response to secondary infection. Agglutinating activity is expressed as the last tube number in a twofold serial dilution assay that gave positive agglutination. Means offive mice per time point + standard error. peak production all but ceased by days 12 to 15 of the primary response and by day 10 of the secondary response. After these times the host retained a small but relatively stable number of protective cells for 40 days or more after peak primary production and probably for at least this length of time after peak secondary production. Further analysis of the production and loss of protective lymphocytes is seen in Fig. 2, where the same results are expressed in terms of protection afforded to normal recipients by dividing (vinblastine-sensitive) and nondividing (vinblastine-resistant) spleen cells. It can be seen that both the primary and secondary response FIG. 2. Production of dividing (vinblastine-sensitive) and nondividing (vinblastine-resistant) protective lymphocytes in response to primary and secondary infection (arrows) compared with changes in the level of spleen cell division ([3H]TdR incorporation into total DNA) and changes in the level of delayed sensitivity to Listeria antigens (footpad increase). The production of replicating protective cells was confined to the short-lived period of increased spleen cell division. The faster production of these cells that occurred in response to secondary infection, therefore, was correlated with a faster increase in spleen cell division. Only nonreplicating protective cells remained after the 12th day of the primary response and changes in their number were closely correlated with changes in the level of delayed sensitivity. Means offive mice per time point ± standard error.

4 764 NORTH AND DEISSLER No detectable agglutinating antibodies were produced in response to primary infection (Fig. 1) in spite of the fact that the antigens used for the passive hemagglutination assay were the same as those used to successfully elicit strong delayed sensitivity reactions. Antibodies to these antigens were produced, however, in response to secondary infection, but all of the agglutinating activity was found to be mercaptoethanol sensitive. The kinetics of production of these agglutinins, furthermore, resembled the kinetics of a primary 19S antibody response. Macrophage activation is confined to the period of dividing mediator cell production. Anti-Listeria immunity, although mediated by sensitized T cells, is expressed by activated macrophages (12). The specific acquisition of activated macrophages, furthermore, enables the host to nonspecifically resist, to varying degrees, infections caused by antigenically unrelated bacteria. It was shown in a preceding paper, moreover, that activated macrophages were not responsible for long-term specific resistance to reinfection, because this resistance was only expressed against the homologous organism. It was proposed, therefore, that activated macrophages acquired during immunizing infection were lost soon after immunizing infection ended. The following experiment was designed to obtain additional information to support this proposition. It involved determining changes in the level of macrophage activation during the course of both a primary and a secondary Listeria infection. Changes in the level of a systemic macrophage activation were determined by measuring changes in the level of nonspecific resistance expressed against a standard intravenous challenge infection with the bacterium Y. enterocoliticia. It was found (Fig. 3) that nonspecific resistance was generated in response to both a primary and a secondary Listeria infection and was of limited duration. Indeed, in both cases, the kinetics of generation of nonspecific resistance showed a striking similarity to the curve for the kinetics of production of dividing mediator cells in the spleen and with the curve for changes in spleen cell division (Fig. 2). Thus, in both infections peak macrophage activation was coincident with peak mediator T-cell production, and activated macrophages were lost soon after the production of mediator T cells ceased in the spleen. It can be further seen that the increased rate of production of mediator T cells that occurred in response to secondary infection was associated with an increased rate of generation of nonspecific resistance. Thus, acquired nonspecific resistance was not present INFECT. IMMUN AA 46 18S SO FIG. 3. Kinetics ofproduction ofprotective lymphocytes during Listeria infection is compared with changes in the level of systemic macrophage activation (histograph) as measured by nonspecific expression of resistance to infection with a standard challenge dose of the bacterium Yersinia enterocolitica (log1o resistance index in liver). The increased tempo ofproduction ofprotective lymphocytes that occurred in response to secondary infection is clearly shown. The kinetics of systemic macrophage activation showed a close temporal correlation with protective T-cell production and therefore occurred faster in response to secondary infection. Macrophages did not remain activated for long after dividing protective T cells are known to have disappeared from the spleen (Fig. 2). Means of five mice per time point ± standard error. during the time period that separated the primary and secondary responses. It is obvious from these results, therefore, that the activated macrophages that were generated to express immunity to primary infection were lost soon after the infecting organism was eliminated from the tissues, and that activated macrophages had to be regenerated at a faster rate in order to express immunity to lethal secondary infection. Capacity to resist secondary infection rests on the presence of nondividing T cells. It was shown in the preceding sections that primary Listeria infection results in the production of dividing and nondividing protective lymphocytes in the spleen. It was also shown that whereas dividing protective cells were lost soon after the termination of immunizing infection, nondividing protective cells persisted in a small but significant number for a long time thereafter. The evidence for the persistence of nondividing cells was based on the finding that about 0.5 log of protection could routinely be transferred to normal recipients with vinblastine-resistant cells harvested from immunized donors for up to 2 months after they had lost their replicating protective T cells. It should be remembered, however, that this small level of adoptive immunity was measured by subtracting the 48-h

5 VOL. 12, 1975 ACTIVE IMMUNE RESPONSE AND "MEMORY" IN T CELLS 765 growth of a Listeria challenge infection in the spleens of recipients of "immune" spleen cells from its 48-h growth in the spleens of recipients of normal spleen cells. This technique, therefore, only measured the early expression of active adoptive immunity and did not give any indication of the way in which the recipients of immune spleen cells handled the challenge infection after 48 h. The possibility existed, therefore, that the small level ofadoptive immunity expressed by recipients at 48 h of a challenge infection could represent the basis for expression of a higher level of immunity after this time. This would be so if nondividing protective donor cells were the progenitors of dividing mediator T cells and if these latter cells needed time to be generated. As a first step in investigating this possibility, it was necessary to determine whether the acquired, long-lived capacity of immunized mice for generating resistance to a lethal Listeria challenge infection, as measured by 3-day growth of the organism in their livers and spleens, could be passively transferred with their spleen cells to normal recipients. This involved comparing the 3-day growth of a lethal challenge infection in 40-day immune donors with its 3-day growth in recipients of two equivalents of spleen cells from the same panel of 40-day immune donors. The rationale for using two equivalents of donor spleen cells was based on the assumption that nondividing protective cells -are part of the long-lived pool of recirculating lymphocytes as are the cells that carry antibody memory (7, 17), and on the knowledge (6) that the spleen contains 50 to 60% of the recirculating pool at any one time. Obviously, the transfer of total anti-listeria immunity from an immune donor to a normal recipient would require that the recipient receive the full complement of the donor's sensitized cells. The possibility that the cells that transferred resistance were T cells was tested by determining their susceptibility to incubation in vitro in anti-o-serum and complement. It was found (Fig. 4) that an infusion of 2 spleen equivalents of cells from 40-day immune donors protected normal recipients against lethal challenge infection as indicated by the progressive elimination of the organism between 48 and 72 h from the liver and between 24 and 48 h from the spleen. Indeed, the timing of the onset of expression of immunity in the spleens of recipient mice was similar to that in the donors. It is apparent, therefore, that in the recipients, as well as the donors, immunity needed time to develop. It will be noted, nevertheless, that the recipients expressed only about half as much resistance as the donors. FIG. 4. Passive transfer to normal recipients of protection against lethal challenge infection with nonreplicating spleen cells from 40-day immune (memory) donors. The recipients, although well protected, expressed only halfas much resistance as the donors. Incubating the spleen cells with anti- 0-serum ablated their capacity to transfer immunity. Means of five mice per time point. Incubation in anti-0-serum completely abrogated the capacity of donor spleen cells to transfer immunity (Fig. 4). It is apparent, therefore, that the long-lived, anit-listeria immunity is dependent on the persistence of a population of nondividing sensitized T cells. DISCUSSION The results of this study can be interpreted to mean that primary intravenous infection with L. monocytogenes in mice resulted in the generation of two distinct states of immunological reactivity. There was both the generation of a short-lived state of active immunity that functioned to eliminate the infecting organism from the tissues and the generation of a long-lived state of heightened immunological potential that enabled the host to combat a secondary infection with greatly increased efficiency. Short-lived active immunity was mediated mostly by replicating, short-lived T cells and is known to be expressed by activated macrophages (12). The activity of both types of cells peaked on day 6 of primary infection and decayed rapidly after the elimination of the infecting organism from the tissues. It is obvious that the state of activity immunity ended when the T cells that mediated this immunity and the macrophages that expressed it disappeared or lost their function. Indeed, the close temporal correlation between the curve for macrophage

6 766 NORTH AND DEISSLER activation and the curve for mediator T-cell production indicates that the level of macrophage activation at any one time was proportional to the level of production of replicating mediator T cells. The host's macrophage system did not remain activated in the absence of replicating mediator T cells. The close temporal correlation between the production of replicating mediator T cells and infection-induced spleen cell division indicates, in tum, that mediator T cells arose by vigorous cell division. Furthermore, because of their short life span (13), replicating mediator cells were not sustained in functional numbers in the absence of cell division. The response to secondary infection showed development of the same temporally correlated parameters as the primary response, except that they developed with a markedly increased tempo. The increased rate of production of mediator T cells and activated macrophages, furthermore, resulted in a faster onset of expression of antibacterial immunity. This prevented the lethal challenge infection from multiplying significantly and results in its rapid elimination from the tissues. As with the active primary response, the cells generated to mediate and express immunity during the active secondary response rapidly disappeared when the secondary infection was eliminated. Despite the disappearance of replicating mediator T cells and effector macrophages that followed termination of primary infection, then, mice remained capable of resisting lethal secondary infection for many weeks because of their acquired capacity for regenerating a state of active immunity in an accelerated fashion. The acquired long-lived state of increased immunological potential on which the accelerated secondary response was based was associated with a persistent level of delayed sensitivity to Listeria antigens and with a small and relatively stable number of nondividing protective T cells. Passive transfer of these protective cells enabled normal recipients to resist a lethal challenge infection. Such cells can also transfer delayed sensitivity (North, submitted for publication). The delay in the onset of the expression of this adoptive resistance indicates, however, that it needed time to develop. Indeed, since the 40-day immune donors of these cells were required to generate an accelerated active secondary immune response to resist the challenge infection, it follows that the recipients also needed to generate an active response. This would mean that the protective, nonreplicating INFECT. IMMUN. T cells in 40-day immune donors were either the progenitors or the recruiters of the replicating mediator T cells that mediated active adoptive immunity. Direct evidence that the recipient of spleen cells from 40-day immune donors have the capacity for an accelerated production of replicating mediator T cells will appear in a forthcoming publication. It should be pointed out that nonreplicating protective T cells were also present in the spleen during the active primary and secondary responses and that a high level of delayed sensitivity also existed during these times. Some of these nonreplicating protective cells may have represented short-lived replicating T cells that had reached the end of their division cycle and were destined to die. Some of them, on the other hand, were probably of the same class as the nonreplicating T cells that persisted long after the active immune response ended and that were associated with a persistent state of delayed sensitivity. Indeed, the close temporal correlation between the curve for changes in the number of nonreplicating protective T cells and that for changes in the level of delayed sensitivity indicates the possibility that nonreplicating protective T cells are the same cells that initiate delayed sensitivity reactions. There is published evidence (1, 2, 8) that the initiators of delayed sensitivity reactions in other models are nonreplicating cells. Thus, the possibility exists that a state of delayed sensitivity represents a state of immunological memory of the cell-mediated type. This would seem to be the only adaptive function that the state of delayed sensitivity could serve. The failure to detect serum antibodies to soluble Listeria antigens during primary Listeria infection by hemagglutination, and the finding that the antibody response to a much larger secondary infection resembled the kinetics of a primary response and generated antibody that was all mercaptoethanol sensitive, indicates that primary infection may not have primed for a secondary antibody response. This model, therefore, may prove useful for determining whether the T cells that function in cell-mediated immunity are different from the T cells that function as helper cells in antibody production, as has been shown to be the case in another published model (16). ACKNOWLEDGMENT This work was supported by Public Health Service grant AI from the National Institute of Allergy and Infectious Diseases. LITERATURE CITED 1. Bloom, B. R., L. D. Hamilton, and M. W. Chase Effects of mitomycin C on the cellular transfer of delayed-type hypersensitivity in the guinea pig. Nature (London) 201: Bloom, B. R., S. Kano, and M. L. Howe Virus

7 VOL. 12, 1975 ACTIVE IMMUNE RESPONSE AND "MEMORY' IN T CELLS 767 plaque assay for enumeration of effector cells in mixed lymphocyte cultures. Transplant. Proc. 5: Carter, P. B., and F. M. Collins Experimental Yersinia enterocolitica in mice: kinetics of growth. Infect. Immun. 9: Celada, F The cellular basis ofimmunologic memory. Prog. Allergy 15: Cunningham, A. J., and E. E. Sercarz The asynchronous development of immunological memory in helper (T) and precursor (B) cell lines. Eur. J. Immunol. 1: Ford, W. L The kinetics of lymphocyte recirculation within the rat spleen. Cell Tissue Kinet. 2: Hunt, S. V., S. T. Ellis, and J. L. Gowans The role of lymphocytes in antibody formation. IV. Carriage of immunological memory by lymphocyte fractions separated by velocity sedimentation and on glass bead columns. Proc. R. Soc. London Ser. B 182: Lagrange, P. H., and G. B. Mackaness A stable form of delayed-type hypersensitivity. J. Exp. Med. 141: Ling, N. R The attachment of proteins to aldehyde-tanned red cells. Br. J. Haematol. 7: North, R. J The cellular mediators of anti-listeria immunity as an enlarged population of short-lived replicating T cells: kinetics of their production. J. Exp. Med. 138: North, R. J T cell dependence of macrophage activation and mobilization during infection with Mycobacterium tuberculosis. Infect. Immun. 10: North, R. J Cell-mediated immunity and the response to infection, p In R. T. McCluskey and S. Cohen (ed.), Mechanisms of cell-mediated immunity. Wiley and Sons, New York. 13. North, R. J T cell-dependent macrophage activation in cell-mediated anti-listeria immunity, p In W.-H. Wagner and H. Hahn (ed.), Activation of macrophages. American Elsevier, New York, and Excerpta Medica, Amsterdam. 14. North, R. J Nature of "memory" in T-cell-mediated antibacterial immunity: anamnestic production of mediator T cells. Infect. Immun. 12: North, R. J., G. B. Mackaness, and R. W. Elliott The histogenesis of immunologically committed lymphocytes. Cell. Immunol. 3: Silver, J., and B. Benacerraf Dissociation of T cell helper function and delayed hypersensitivity. J. Immunol. 113: Strober, S., and J. Dilley Biological characteristics of T and B memory lymphocytes in the rat. J. Exp. Med. 137:

SUBVERSION OF HOST DEFENSE MECHANISMS BY MURINE TUMORS II. Counter-Influence of Concomitant Antitumor Immunity*

SUBVERSION OF HOST DEFENSE MECHANISMS BY MURINE TUMORS II. Counter-Influence of Concomitant Antitumor Immunity* Published Online: 1 March, 1976 Supp Info: http:doi.org10.1084jem.143.3.574 Downloaded from jem.rupress.org on December 30, 2018 SUBVERSION OF HOST DEFENSE MECHANISMS BY MURINE TUMORS II. Counter-Influence

More information

Immunologically Induced and Elicited Local

Immunologically Induced and Elicited Local INFECTION AND IMMUNITY, Dec. 1970, p. 757-761 Copyright 1970 American Society for Microbiology Vol. 2, No. 6 Printed in U.S.A. Immunologically Induced and Elicited Local Resistance to Staphylococcus aureus

More information

however, and the present communication is concerned with some of

however, and the present communication is concerned with some of THE AGGLUTINATION OF HUMAN ERYTHROCYTES MODIFIED BY TREATMENT WITH NEWCASTLE DISEASE AND INFLUENZA VIRUS' ALFRED L. FLORMAN' Pediatric Service and Division of Bacteriology, The Mount Sinai Hospital, New

More information

Effect of Vaccine, Route, and Schedule on Antibody

Effect of Vaccine, Route, and Schedule on Antibody APPUED MICROBIOLOGY, Mar. 1969, p. 355-359 Copyright 1969 American Society for Microbiology Vol. 17, No. 3 Printed in U.S.A. Effect of Vaccine, Route, and Schedule on Antibody Response of Rabbits to Pasteurella

More information

A STABLE FORM OF DELAYED-TYPE HYPERSENSITIVITY*

A STABLE FORM OF DELAYED-TYPE HYPERSENSITIVITY* A STABLE FRM F DELAYED-TYPE HYPERSENSITIVITY* By P. H. LAGRANGEt, AND G. B. MACKANESS (From the Trudeau Institute, Inc., Saranac Lake, N. Y. 1983) Delayed-type hypersensitivity (DTH) 1 develops naturally

More information

Chapter 22: The Lymphatic System and Immunity

Chapter 22: The Lymphatic System and Immunity Bio40C schedule Lecture Immune system Lab Quiz 2 this week; bring a scantron! Study guide on my website (see lab assignments) Extra credit Critical thinking questions at end of chapters 5 pts/chapter Due

More information

Chapter 40 Section 2 The Immune System

Chapter 40 Section 2 The Immune System Chapter 40 Section 2 The Immune System Science Standard 10a What is the role of the skin in providing nonspecific defenses against infection? What is the function of the immune system? The immune system

More information

(b) Describe the role of antigen presentation in the body s specific immune response to infection by viruses. (4)

(b) Describe the role of antigen presentation in the body s specific immune response to infection by viruses. (4) 1 The human body responds to infection by viruses in a number of ways. The non-specific response involves interferon. The specific immune response requires antigen presentation to the cells of the immune

More information

(From the Department of Medicine, New York University School of Medicine, New York)

(From the Department of Medicine, New York University School of Medicine, New York) THE IN VITRO DESENSITIZATION OF SENSITIVE CELLS BY TRYPSIN* Bx JOHN R. DAVID,~t M.D., H. S. LAWRENCE, M.D., AND L. THOMAS, M.D. (From the Department of Medicine, New York University School of Medicine,

More information

EBV and Infectious Mononucleosis. Infectious Disease Definitions. Infectious Diseases

EBV and Infectious Mononucleosis. Infectious Disease Definitions. Infectious Diseases Infectious Disease Definitions Infection when a microorganism invades a host and multiplies enough to disrupt normal function by causing signs and symptoms Pathogencity ability of an organism to cause

More information

(From the Department of Microbiology, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania 15213)

(From the Department of Microbiology, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania 15213) LYMPHOID CELLS IN DELAYED HYPERSENSITIVITY III. THE INFLUENCE OF X-IRRADIATION ON PASSIVE TRANSFER AND ON IN VITRO PRODUCTION OF SOLUBLE MEDIATORS* BY S. B. SALVIN Am) J. NISHIO (From the Department of

More information

MACROPHAGE ACTIVATION IN MICE INFECTED WITH ECTROMELIA OR LYMPHOCYTIC CHORIOMENINGITIS VIRUSES

MACROPHAGE ACTIVATION IN MICE INFECTED WITH ECTROMELIA OR LYMPHOCYTIC CHORIOMENINGITIS VIRUSES AJEBAK 51 (Pt. 3) 393-398 (1973) MACROPHAGE ACTIVATION IN MICE INFECTED WITH ECTROMELIA OR LYMPHOCYTIC CHORIOMENINGITIS VIRUSES by R. V. BLANDEN AND C. A. MIMS' (From the Department of Microbiology, John

More information

Third line of Defense

Third line of Defense Chapter 15 Specific Immunity and Immunization Topics -3 rd of Defense - B cells - T cells - Specific Immunities Third line of Defense Specific immunity is a complex interaction of immune cells (leukocytes)

More information

The Immune System: Innate and Adaptive Body Defenses Outline PART 1: INNATE DEFENSES 21.1 Surface barriers act as the first line of defense to keep

The Immune System: Innate and Adaptive Body Defenses Outline PART 1: INNATE DEFENSES 21.1 Surface barriers act as the first line of defense to keep The Immune System: Innate and Adaptive Body Defenses Outline PART 1: INNATE DEFENSES 21.1 Surface barriers act as the first line of defense to keep invaders out of the body (pp. 772 773; Fig. 21.1; Table

More information

Chlorphenesin: an Antigen-Associated Immunosuppressant

Chlorphenesin: an Antigen-Associated Immunosuppressant INFECTION AND IMMUNITY, JUlY 197, p. 6-64 Vol. 2, No. 1 Copyright 197 American Society for Microbiology Printed in U.S.A. Chlorphenesin: an Antigen-Associated Immunosuppressant H. Y. WHANG AND E. NETER

More information

The Lymphatic System and Body Defenses

The Lymphatic System and Body Defenses PowerPoint Lecture Slide Presentation by Patty Bostwick-Taylor, Florence-Darlington Technical College The Lymphatic System and Body Defenses 12PART B Adaptive Defense System: Third Line of Defense Immune

More information

Chapter 24 The Immune System

Chapter 24 The Immune System Chapter 24 The Immune System The Immune System Layered defense system The skin and chemical barriers The innate and adaptive immune systems Immunity The body s ability to recognize and destroy specific

More information

(From the Trudeau Institute, Inc., Saranac Lake, New York 12983)

(From the Trudeau Institute, Inc., Saranac Lake, New York 12983) THE RELATIVE IMPORTANCE OF BLOOD MONOCYTES AND FIXED MACROPHAGES TO THE EXPRESSION OF CELL-MEDIATED IMMUNITY TO INFECTION* BY R. J. NORTH, ProD. (From the Trudeau Institute, Inc., Saranac Lake, New York

More information

CELLULAR KINETICS OF THE ANTI-MRBC RESPONSE IN CHICKENS

CELLULAR KINETICS OF THE ANTI-MRBC RESPONSE IN CHICKENS 19 CELLULAR KINETICS OF THE ANTI-MRBC RESPONSE IN CHICKENS K. Dagg, S. P. Turner and F. Seto Department of Zoology, University of Oklahoma, Norman, Oklahoma The serum hemagglutinin (HA) titers and the

More information

The Immune System. Specific Immunity

The Immune System. Specific Immunity The Immune System Specific Immunity What You Should Know Immune surveillance A range of white blood cells constantly circulate monitoring the tissues. If tissues become damaged or invaded, cells release

More information

Immunity. Avian Physiology

Immunity. Avian Physiology Immunity Avian Physiology The Perfect World The Real World HELP ME! CHICKEN POX FLU STOMACH UPSET HELP! COLD HELP ME! Immunity Definition The Latin term IMMUNIS means EXEMPT, referring to protection against

More information

SOME OBSERVATIONS UPON SODIUM ALGINATE. By 0. M. SOLANDT. From the Physiological Laboratory, Cambridge.

SOME OBSERVATIONS UPON SODIUM ALGINATE. By 0. M. SOLANDT. From the Physiological Laboratory, Cambridge. 582.6 SOME OBSERVATIONS UPON SODIUM ALGINATE. By 0. M. SOLANDT. From the Physiological Laboratory, Cambridge. (Received for publication 13th December 1940.) ALGINIC acid was discovered by Stanford in 1883

More information

I. Lines of Defense Pathogen: Table 1: Types of Immune Mechanisms. Table 2: Innate Immunity: First Lines of Defense

I. Lines of Defense Pathogen: Table 1: Types of Immune Mechanisms. Table 2: Innate Immunity: First Lines of Defense I. Lines of Defense Pathogen: Table 1: Types of Immune Mechanisms Table 2: Innate Immunity: First Lines of Defense Innate Immunity involves nonspecific physical & chemical barriers that are adapted for

More information

Tuberculin-Specific Transfer Factor in Dogs

Tuberculin-Specific Transfer Factor in Dogs INFECTION AND IMMUNrrY, Oct. 1977, p. 73-77 Copyright 1977 American Society for Microbiology Vol. 18, No. 1 Printed in U.S.A. Tuberculin-Specific Transfer Factor in Dogs MICHAEL R. SIMON,t* JOSEPH SILVA,

More information

NOTES: CH 43, part 2 Immunity; Immune Disruptions ( )

NOTES: CH 43, part 2 Immunity; Immune Disruptions ( ) NOTES: CH 43, part 2 Immunity; Immune Disruptions (43.3-43.4) Activated B & T Lymphocytes produce: CELL-MEDIATED IMMUNE RESPONSE: involves specialized T cells destroying infected host cells HUMORAL IMMUNE

More information

Campbell's Biology: Concepts and Connections, 7e (Reece et al.) Chapter 24 The Immune System Multiple-Choice Questions

Campbell's Biology: Concepts and Connections, 7e (Reece et al.) Chapter 24 The Immune System Multiple-Choice Questions Campbell's Biology: Concepts and Connections, 7e (Reece et al.) Chapter 24 The Immune System 24.1 Multiple-Choice Questions 1) The body's innate defenses against infection include A) several nonspecific

More information

(From the Department of Epidemiology and Virus Laboratory, School of Pubbic Health, University of Michigan, Ann Arbor) Methods

(From the Department of Epidemiology and Virus Laboratory, School of Pubbic Health, University of Michigan, Ann Arbor) Methods Published Online: 1 November, 1948 Supp Info: http://doi.org/1.184/jem.88.5.515 Downloaded from jem.rupress.org on May 3, 218 THE RELATION OF INFECTIOUS AND HEMAGGLUTINATION TITERS TO THE ADAPTATION OF

More information

The Lymphatic System and Immunity. Chapters 20 & 21

The Lymphatic System and Immunity. Chapters 20 & 21 The Lymphatic System and Immunity Chapters 20 & 21 Objectives 1. SC.912.L.14.52 - Explain the basic functions of the human immune system, including specific and nonspecific immune response, vaccines, and

More information

By ROBERT J. NORTH. From the Trudeau Institute, Inc., Saranac Lake, New York 12983

By ROBERT J. NORTH. From the Trudeau Institute, Inc., Saranac Lake, New York 12983 RADIATI-IDUCED, IMMULGICALLY MEDIATED REGRESSI F A ESTABLISHED TUMR AS A EXAMPLE F SUCCESSFUL THERAPEUTIC IMMUMAIPULATI Preferential Elimination of Suppressor T Cells Allows Sustained Production of Effector

More information

Cell Mediated Immunity CELL MEDIATED IMMUNITY. Basic Elements of Cell Mediated Immunity (CMI) Antibody-dependent cell-mediated cytotoxicity (ADCC)

Cell Mediated Immunity CELL MEDIATED IMMUNITY. Basic Elements of Cell Mediated Immunity (CMI) Antibody-dependent cell-mediated cytotoxicity (ADCC) Chapter 16 CELL MEDIATED IMMUNITY Cell Mediated Immunity Also known as Cellular Immunity or CMI The effector phase T cells Specificity for immune recognition reactions TH provide cytokines CTLs do the

More information

Immunology: an overview Lecture

Immunology: an overview Lecture Slide #2: Immunology is sometimes regarded as part of microbiology department because it started there as an investigation of ways used to prevent against infectious agents (e.g. microorganisms ). However

More information

Chapter 1. Full file at

Chapter 1. Full file at Chapter 1 1. Which is the best definition of immunity? Answer: B A. The state of having been exposed to a pathogen repeatedly B. The state of being resistant to reinfection with a pathogen C. When an individual

More information

Animal model for testing human Ascaris allergens

Animal model for testing human Ascaris allergens J. Biosci., Vol. 3 Number 1, March 1981, pp. 77-82. Printed in India. Animal model for testing human Ascaris allergens KRISHNA MUKERJI*, R. P. SAXENA, S. N. GHATAK and K. C. SAXENA Division of Biochemistry,

More information

Immunology 2011 Lecture 2 Immune Reactions, Ag/Ab 20 September

Immunology 2011 Lecture 2 Immune Reactions, Ag/Ab 20 September Immunology 2011 Lecture 2 Immune Reactions, Ag/Ab 20 September HANDOUTS #1 Roadmap TODAY Immune Reactions, Antigen/Antibody, Core Notes Chapters 1 & 2 and Appendix 1,2 (Precipitin Curve, Ab Labeling) Ag/Ab

More information

Immune System Notes Innate immunity Acquired immunity lymphocytes, humoral response Skin lysozyme, mucus membrane

Immune System Notes Innate immunity Acquired immunity lymphocytes, humoral response Skin lysozyme, mucus membrane Immune System Notes I. The immune system consists of innate and acquired immunity. A. An animal must defend itself against unwelcome intruders the many potentially dangerous viruses, bacteria, and other

More information

Antibody-Mediated and Delayed-Type Hypersensitivity

Antibody-Mediated and Delayed-Type Hypersensitivity INFECriON AND IMMUNITY, Feb. 1975, p. 360-364 Copyright 0 1975 American Society for Microbiology Vol. 11, No. 2 Printed in U.S.A. Antibody-Mediated and Delayed-Type Hypersensitivity Reactions to Brucella

More information

Downloaded by on April 28, 2018 https://pubs.acs.org Publication Date: April 24, 1984 doi: /bk

Downloaded by on April 28, 2018 https://pubs.acs.org Publication Date: April 24, 1984 doi: /bk 1 Virus-Receptor Interactions BERNARD N. FIELDS Department of Microbiology and Molecular Genetics, Harvard Medical School, and Department of Medicine (Infectious Disease), Brigham and Women's Hospital,

More information

Third line of Defense. Topic 8 Specific Immunity (adaptive) (18) 3 rd Line = Prophylaxis via Immunization!

Third line of Defense. Topic 8 Specific Immunity (adaptive) (18) 3 rd Line = Prophylaxis via Immunization! Topic 8 Specific Immunity (adaptive) (18) Topics - 3 rd Line of Defense - B cells - T cells - Specific Immunities 1 3 rd Line = Prophylaxis via Immunization! (a) A painting of Edward Jenner depicts a cow

More information

Immunological transfusion reactions

Immunological transfusion reactions Immunological transfusion reactions Immunological transfusion reactions can be hemolytic or non-hemolytic in nature. Both types can be separated into acute (those occurring immediately after transfusion)

More information

ENHANCING EFFECT OF COENZYME Q10 ON IMMUNORESTORATION WITH MYCOBACTERIUM BOVIS BCG IN TUMOR-BEARING MICE*1

ENHANCING EFFECT OF COENZYME Q10 ON IMMUNORESTORATION WITH MYCOBACTERIUM BOVIS BCG IN TUMOR-BEARING MICE*1 ENHANCING EFFECT OF COENZYME Q10 ON IMMUNORESTORATION WITH MYCOBACTERIUM BOVIS BCG IN TUMOR-BEARING MICE*1 Ichiro KAWASE, Hisanobu NIITANI, Nagahiro SAIJO, Haruo SASAKI, and Tatsuhide MORITA National Cancer

More information

MCAT Biology - Problem Drill 16: The Lymphatic and Immune Systems

MCAT Biology - Problem Drill 16: The Lymphatic and Immune Systems MCAT Biology - Problem Drill 16: The Lymphatic and Immune Systems Question No. 1 of 10 1. Which of the following statements about pathogens is true? Question #01 (A) Both viruses and bacteria need to infect

More information

Lymphatic System. The targets of the immune defenses are infectious organisms such as,, parasites, fungi, and some protists.

Lymphatic System. The targets of the immune defenses are infectious organisms such as,, parasites, fungi, and some protists. Lymphatic System I. Non-specific Defenses The immune system is a body wide network of cells and organs that have evolved to defend the body against attacks by invaders. The targets of the immune defenses

More information

Experiment #1 TARGET Mouse Model Group. Report prepared by Paul Converse, Ph.D. and Eric Nuermberger, M.D. March 1, 2006

Experiment #1 TARGET Mouse Model Group. Report prepared by Paul Converse, Ph.D. and Eric Nuermberger, M.D. March 1, 2006 Protocol for in vivo evaluation of growth rates and pathogenesis of M. tuberculosis strains found to have rapid or slow growth phenotypes in an in vitro model Experiment #1 TARGET Mouse Model Group Report

More information

COURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16

COURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16 COURSE: Medical Microbiology, PAMB 650/720 - Fall 2008 Lecture 16 Tumor Immunology M. Nagarkatti Teaching Objectives: Introduction to Cancer Immunology Know the antigens expressed by cancer cells Understand

More information

Fluid movement in capillaries. Not all fluid is reclaimed at the venous end of the capillaries; that is the job of the lymphatic system

Fluid movement in capillaries. Not all fluid is reclaimed at the venous end of the capillaries; that is the job of the lymphatic system Capillary exchange Fluid movement in capillaries Not all fluid is reclaimed at the venous end of the capillaries; that is the job of the lymphatic system Lymphatic vessels Lymphatic capillaries permeate

More information

Chapter 24 The Immune System

Chapter 24 The Immune System Chapter 24 The Immune System PowerPoint Lectures for Biology: Concepts & Connections, Sixth Edition Campbell, Reece, Taylor, Simon, and Dickey Lecture by Edward J. Zalisko Introduction: The Kissing Disease?!?

More information

STUDIES OF THE HEMAGGLUTININ OF HAEMOPHILUS PERTUSSIS HIDEO FUKUMI, HISASHI SHIMAZAKI, SADAO KOBAYASHI AND TATSUJI UCHIDA

STUDIES OF THE HEMAGGLUTININ OF HAEMOPHILUS PERTUSSIS HIDEO FUKUMI, HISASHI SHIMAZAKI, SADAO KOBAYASHI AND TATSUJI UCHIDA STUDIES OF THE HEMAGGLUTININ OF HAEMOPHILUS PERTUSSIS HIDEO FUKUMI, HISASHI SHIMAZAKI, SADAO KOBAYASHI AND TATSUJI UCHIDA The National Institute of Health, Tokyo, Japan (Received: August 3rd, 1953) INTRODUCTION

More information

Guided Reading Activities

Guided Reading Activities Name Period Chapter 24: The Immune System Guided Reading Activities Big idea: Innate immunity Answer the following questions as you read modules 24.1 24.2: 1. Bacteria, viruses, and other microorganisms

More information

Overview of the Lymphoid System

Overview of the Lymphoid System Overview of the Lymphoid System The Lymphoid System Protects us against disease Lymphoid system cells respond to Environmental pathogens Toxins Abnormal body cells, such as cancers Overview of the Lymphoid

More information

Introduction.-Cytopathogenic viruses may lose their cell-destroying capacity

Introduction.-Cytopathogenic viruses may lose their cell-destroying capacity AN INHIBITOR OF VIRAL ACTIVITY APPEARING IN INFECTED CELL CULTURES* BY MONTO Hot AND JOHN F. ENDERS RESEARCH DIVISION OF INFECTIOUS DISEASES, THE CHILDREN'S MEDICAL CENTER, AND THE DEPARTMENT OF BACTERIOLOGY

More information

tuberculosis in Rats

tuberculosis in Rats INFECTION AND IMMUNITY, Aug. 1973, p. 182-189 Vol. 8, No. 2 Copyright ( 1973 American Society for Microbiology Printed in U.S.A. Immune Response to Mycobacterium tuberculosis in Rats M. J. LEFFORD, D.

More information

3. Lymphocyte proliferation (fig. 15.4): Clones of responder cells and memory cells are derived from B cells and T cells.

3. Lymphocyte proliferation (fig. 15.4): Clones of responder cells and memory cells are derived from B cells and T cells. Chapter 15 Adaptive, Specific Immunity and Immunization* *Lecture notes are to be used as a study guide only and do not represent the comprehensive information you will need to know for the exams. Specific

More information

Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D

Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D AppuzD MmcoaioLOGy, Apr. 1973, p. 539-544. Copyright i 1973 American Society for Microbiology Vol. 25, No. 4 Printed in U.SA. Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D

More information

IN VITRO CELLULAR RESPONSES TO AUTOLOGOUS TUMOR EXTRACT DETECTED BY INHIBITION OF MACROPHAGE MIGRATION*1

IN VITRO CELLULAR RESPONSES TO AUTOLOGOUS TUMOR EXTRACT DETECTED BY INHIBITION OF MACROPHAGE MIGRATION*1 [Gann, 66, 167-174; April, 1975] IN VITRO CELLULAR RESPONSES TO AUTOLOGOUS TUMOR EXTRACT DETECTED BY INHIBITION OF MACROPHAGE MIGRATION*1 Tsuyoshi AKIYOSHI, Akira HATA, and Hideo TSUJI Department of Surgery,

More information

(From the Laboratories of The Rockefeller Institute for Medical Research)

(From the Laboratories of The Rockefeller Institute for Medical Research) ON THE EXISTENCE OF A FACTOR INCREASING TISSUE PERMEABILITY IN ORGANS OTHER THAN TESTICLE BY ALBERT CLAUDE, M.D., AI~ F. DURAN-REYNALS, M.D. (From the Laboratories of The Rockefeller Institute for Medical

More information

Diseases-causing agents, pathogens, can produce infections within the body.

Diseases-causing agents, pathogens, can produce infections within the body. BIO 212: ANATOMY & PHYSIOLOGY II 1 CHAPTER 16 Lecture: Dr. Lawrence G. Altman www.lawrencegaltman.com Some illustrations are courtesy of McGraw-Hill. LYMPHATIC and IMMUNE Systems Body Defenses Against

More information

Blood and Immune system Acquired Immunity

Blood and Immune system Acquired Immunity Blood and Immune system Acquired Immunity Immunity Acquired (Adaptive) Immunity Defensive mechanisms include : 1) Innate immunity (Natural or Non specific) 2) Acquired immunity (Adaptive or Specific) Cell-mediated

More information

Immunology Lecture 4. Clinical Relevance of the Immune System

Immunology Lecture 4. Clinical Relevance of the Immune System Immunology Lecture 4 The Well Patient: How innate and adaptive immune responses maintain health - 13, pg 169-181, 191-195. Immune Deficiency - 15 Autoimmunity - 16 Transplantation - 17, pg 260-270 Tumor

More information

What is the immune system? Types of Immunity. Pasteur and rabies vaccine. Historical Role of smallpox. Recognition Response

What is the immune system? Types of Immunity. Pasteur and rabies vaccine. Historical Role of smallpox. Recognition Response Recognition Response Effector memory What is the immune system? Types of Immunity Innate Adaptive Anergy: : no response Harmful response: Autoimmunity Historical Role of smallpox Pasteur and rabies vaccine

More information

General Biology. A summary of innate and acquired immunity. 11. The Immune System. Repetition. The Lymphatic System. Course No: BNG2003 Credits: 3.

General Biology. A summary of innate and acquired immunity. 11. The Immune System. Repetition. The Lymphatic System. Course No: BNG2003 Credits: 3. A summary of innate and acquired immunity General iology INNATE IMMUNITY Rapid responses to a broad range of microbes Course No: NG00 Credits:.00 External defenses Invading microbes (pathogens). The Immune

More information

Chapter 1. Chapter 1 Concepts. MCMP422 Immunology and Biologics Immunology is important personally and professionally!

Chapter 1. Chapter 1 Concepts. MCMP422 Immunology and Biologics Immunology is important personally and professionally! MCMP422 Immunology and Biologics Immunology is important personally and professionally! Learn the language - use the glossary and index RNR - Reading, Note taking, Reviewing All materials in Chapters 1-3

More information

Lymphatic System and Immune System. Blood capillaries. Lymphatic vessels/ lymph nodes. Then, identify by labeling these specific structures in part B.

Lymphatic System and Immune System. Blood capillaries. Lymphatic vessels/ lymph nodes. Then, identify by labeling these specific structures in part B. Name: Date: Period: Lymphatic System and Immune System 1. Figure 21.1 provides an overview of the lymphatic vessels. In part A the relationship between lymphatic vessels and the blood vessels of the cardiovascular

More information

CHAPTER 10 BLOOD GROUPS: ABO AND Rh

CHAPTER 10 BLOOD GROUPS: ABO AND Rh CHAPTER 10 BLOOD GROUPS: ABO AND Rh The success of human blood transfusions requires compatibility for the two major blood group antigen systems, namely ABO and Rh. The ABO system is defined by two red

More information

Properties & Overview of IRs Dr. Nasser M. Kaplan JUST, Jordan. 10-Jul-16 NM Kaplan 1

Properties & Overview of IRs Dr. Nasser M. Kaplan JUST, Jordan. 10-Jul-16 NM Kaplan 1 Properties & Overview of IRs Dr. Nasser M. Kaplan JUST, Jordan 10-Jul-16 NM Kaplan 1 Major components of IS & their properties Definitions IS = cells & molecules responsible for: 1- Physiologic; protective

More information

Defense mechanism against pathogens

Defense mechanism against pathogens Defense mechanism against pathogens Immune System What is immune system? Cells and organs within an animal s body that contribute to immune defenses against pathogens ( ) Bacteria -Major entry points ;open

More information

Chapter 12: The Lymphatic System

Chapter 12: The Lymphatic System Chapter 12: The Lymphatic System Immune System Composed of many nonspecific and specific defenses Lymphatic System also plays an important role in establishing immunity Lymphatic System Major components

More information

Chapter 17. The Lymphatic System and Immunity. Copyright 2010, John Wiley & Sons, Inc.

Chapter 17. The Lymphatic System and Immunity. Copyright 2010, John Wiley & Sons, Inc. Chapter 17 The Lymphatic System and Immunity Immunity Innate Immunity Fast, non-specific and no memory Barriers, ph extremes, Phagocytes & NK cells, fever, inflammation, complement, interferon Adaptive

More information

Principles of Adaptive Immunity

Principles of Adaptive Immunity Principles of Adaptive Immunity Chapter 3 Parham Hans de Haard 17 th of May 2010 Agenda Recognition molecules of adaptive immune system Features adaptive immune system Immunoglobulins and T-cell receptors

More information

Mon, Wed, Fri 11:00 AM-12:00 PM. Owen, Judy, Jenni Punt, and Sharon Stranford Kuby-Immunology, 7th. Edition. W.H. Freeman and Co., New York.

Mon, Wed, Fri 11:00 AM-12:00 PM. Owen, Judy, Jenni Punt, and Sharon Stranford Kuby-Immunology, 7th. Edition. W.H. Freeman and Co., New York. Course Title: Course Number: Immunology Biol-341/541 Semester: Fall 2013 Location: HS 268 Time: Instructor: 8:00-9:30 AM Tue/Thur Dr. Colleen M. McDermott Office: Nursing Ed 101 (424-1217) E-mail*: mcdermot@uwosh.edu

More information

White Blood Cells (WBCs)

White Blood Cells (WBCs) YOUR ACTIVE IMMUNE DEFENSES 1 ADAPTIVE IMMUNE RESPONSE 2! Innate Immunity - invariant (generalized) - early, limited specificity - the first line of defense 1. Barriers - skin, tears 2. Phagocytes - neutrophils,

More information

Ali Alabbadi. Bann. Bann. Dr. Belal

Ali Alabbadi. Bann. Bann. Dr. Belal 31 Ali Alabbadi Bann Bann Dr. Belal Topics to be discussed in this sheet: Particles-to-PFU Single-step and multi-step growth cycles Multiplicity of infection (MOI) Physical measurements of virus particles

More information

9/10/2018. Principles of Vaccination. Immunity. Antigen. September 2018

9/10/2018. Principles of Vaccination. Immunity. Antigen. September 2018 Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Principles of Vaccination September 2018 Chapter 1 September 2018 Photographs and images included in

More information

For questions 1-5, match the following with their correct descriptions. (24-39) A. Class I B. Class II C. Class III D. TH1 E. TH2

For questions 1-5, match the following with their correct descriptions. (24-39) A. Class I B. Class II C. Class III D. TH1 E. TH2 Questions Made by SI ATTENDEES!! :) Page 1 of 6 Student-Made Practice Exam Activity All questions, answers, and slide numbers are based off of Monday s SI activity, where students/attendees created possible

More information

Principles of Vaccination

Principles of Vaccination Immunology and Vaccine-Preventable Diseases Immunology is a complicated subject, and a detailed discussion of it is beyond the scope of this text. However, an understanding of the basic function of the

More information

IMMUNITY. Stage 1. Stage 2. Stage 3. Stage 4. (a) Describe one method by which antibodies specific to a disease might have been produced.

IMMUNITY. Stage 1. Stage 2. Stage 3. Stage 4. (a) Describe one method by which antibodies specific to a disease might have been produced. QUESTIONSHEET 1 The diagram shows a system for detecting the presence of a disease organism in the blood of an infected person. Stage 1 Antibody specific to the disease organism is bound to the surface

More information

Immunology 2011 Lecture 11 Innate Immunity & Genetics of Inbreeding. 6 October

Immunology 2011 Lecture 11 Innate Immunity & Genetics of Inbreeding. 6 October Immunology 2011 Lecture 11 Innate Immunity & Genetics of Inbreeding 6 October HANDOUT #6, Problem Set 3 TODAY Innate Immunity no core notes Genetics of Inbreeding - Appendix 10 MHC & Transplantation, Chapter

More information

Mechanism of Pock Formation by Shope Fibroma

Mechanism of Pock Formation by Shope Fibroma JOURNAL OF BACTERIOLOGY, Sept., 1966 Copyright ( 1966 American Society for Microbiology Vol. 92, No. 3 Printed in U.S.A. Mechanism of Pock Formation by Shope Fibroma Virus on Monolayers of Rabbit Cells

More information

Effects of prednisolone on murine strongyloidiasis

Effects of prednisolone on murine strongyloidiasis Parasitology (1981), 83, 401-409 With 2 figures in the text Effects of prednisolone on murine strongyloidiasis D. I. GROVE and H. J. S. DAWKINS Department of Medicine, University of Western Australia and

More information

PATHOGENS AND DEFENCE AGAINST INFECTIOUS DISEASE. By: Stephanie, Emily, Cem, and Julie

PATHOGENS AND DEFENCE AGAINST INFECTIOUS DISEASE. By: Stephanie, Emily, Cem, and Julie PATHOGENS AND DEFENCE AGAINST INFECTIOUS DISEASE By: Stephanie, Emily, Cem, and Julie Pathogen Pathogen: an organism or virus that causes a disease. Examples: bacteria, fungi, protozoa, virus Disease Cause

More information

EXPERIMENTAL SALMONELLOSIS

EXPERIMENTAL SALMONELLOSIS EXPERIMENTAL SALMONELLOSIS INTRACELLULAR GROWTH OF Salmonella enteritidis INGESTED IN MONONUCLEAR PHAGOCYTES OF MICE, AND CELLULAR BASIS OF IMMUNITY SUSUMU MITSUHASHI, ICHIEI SATO, AND TOKUMITSU TANAKA

More information

Chapter 38- Immune System

Chapter 38- Immune System Chapter 38- Immune System First Line of Defense: Barriers Nonspecific defenses, such as the skin and mucous membranes, are barriers to potential pathogens. In addition to being a physical barrier to pathogens,

More information

What are bacteria? Microbes are microscopic(bacteria, viruses, prions, & some fungi etc.) How do the sizes of our cells, bacteria and viruses compare?

What are bacteria? Microbes are microscopic(bacteria, viruses, prions, & some fungi etc.) How do the sizes of our cells, bacteria and viruses compare? 7.1 Microbes, pathogens and you Chp. 7 Lymphatic System & Immunity The interaction between microbes and humans? Microbes are very abundant in the environment and as well as in and on our bodies GOOD: We

More information

Body Defense Mechanisms

Body Defense Mechanisms BIOLOGY OF HUMANS Concepts, Applications, and Issues Fifth Edition Judith Goodenough Betty McGuire 13 Body Defense Mechanisms Lecture Presentation Anne Gasc Hawaii Pacific University and University of

More information

AGGLUTINATION PHENOMENA IN CANCER

AGGLUTINATION PHENOMENA IN CANCER AGGLUTINATION PHENOMENA IN CANCER N. WATERMAN AND L. DB KROMME (Laboratory of the Antoni van Leeuwenhoekhuie, Amsterdam) In the course of our investigations into the cytolysis of cancer cells by different

More information

SURVIVAL AFTER TRANSFUSION OF Rh-POSITIVE ERYTHROCYTES PREVIOUSLY INCUBATED

SURVIVAL AFTER TRANSFUSION OF Rh-POSITIVE ERYTHROCYTES PREVIOUSLY INCUBATED J. clin. Path. (1949), 2, 109 SURVIVAL AFTER TRANSFUSION OF Rh-POSITIVE ERYTHROCYTES PREVIOUSLY INCUBATED WITH Rh ANTIBODY BY P. L. MOLLISON From the Medical Research Council Blood Transfusion Research

More information

The Lecture s topics

The Lecture s topics The Lecture s topics Blood groups -ABO system *Transfusion reaction -Rhesus factor *Hemolytic disease of newborn Blood transfusion and Tissue transplant The ABO System Discovered in 1901 by Dr. Karl Landsteiner

More information

ACTIVE AND PASSIVE IMMUNITY TO PNEUMOCOCCUS INFECTION INDUCED IN RABBITS BY IMMUNI- ZATION WITH R PNEUMOCOCCI.

ACTIVE AND PASSIVE IMMUNITY TO PNEUMOCOCCUS INFECTION INDUCED IN RABBITS BY IMMUNI- ZATION WITH R PNEUMOCOCCI. ACTIVE AND PAIVE IMMUNITY TO PNEUMOCOCCU INFECTION INDUCED IN RABBIT BY IMMUNI- ZATION WITH R PNEUMOCOCCI. BY WILLIAM. TILLETT, M.D. Frora the Hospital of The Rockefeller Institute for Medical Research.)

More information

Prof. Ibtesam Kamel Afifi Professor of Medical Microbiology & Immunology

Prof. Ibtesam Kamel Afifi Professor of Medical Microbiology & Immunology By Prof. Ibtesam Kamel Afifi Professor of Medical Microbiology & Immunology Lecture objectives: At the end of the lecture you should be able to: Enumerate features that characterize acquired immune response

More information

3/28/2012. Immune System. Activation of Innate Immunity. Innate (non-specific) Immunity

3/28/2012. Immune System. Activation of Innate Immunity. Innate (non-specific) Immunity Chapter 5 Outline Defense Mechansims Functions of B Lymphocytes Functions of T Lymphocytes Active and Passive Immunity Tumor Immunology Diseases Caused By Immune System Immune System Anatomy - Lymphoid

More information

Effector T Cells and

Effector T Cells and 1 Effector T Cells and Cytokines Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School 2 Lecture outline Cytokines Subsets of CD4+ T cells: definitions, functions, development New

More information

against phage B was prepared by intravenous inoculation of 5 pound rabbits CORYNEBACTERIUM DIPHTHERIAE1

against phage B was prepared by intravenous inoculation of 5 pound rabbits CORYNEBACTERIUM DIPHTHERIAE1 FURTHER OBSERVATIONS ON THE CHANGE TO VIRULENCE OF BACTERIOPHAGE-INFECTED AVIRULENT STRAINS OF CORYNEBACTERIUM DIPHTHERIAE1 VICTOR J. FREEMAN" AND I. UNA MORSE Department of Public Health and Preventive

More information

INTRABULBAR INOCULATION OF JAPANESE ENCEPHALITIS VIRUS TO MICE

INTRABULBAR INOCULATION OF JAPANESE ENCEPHALITIS VIRUS TO MICE THE KURUME MEDICAL JOURNAL Vol. 15, No. 1, 1968 INTRABULBAR INOCULATION OF JAPANESE ENCEPHALITIS VIRUS TO MICE TOSHINORI TSUCHIYA Department of Microbiology, and Department of Ophthalmology, Kurume University

More information

KEY CONCEPT Germs cause many diseases in humans.

KEY CONCEPT Germs cause many diseases in humans. 31.1 40.1 Pathogens Infectious Diseases and Human Illness KEY CONCEPT Germs cause many diseases in humans. 31.1 40.1 Pathogens Infectious Diseases and Human Illness Germ theory states that microorganisms

More information

Presented by DR. NUSRAT SIDDIQUA Phase B student. Department of Microbiology & Immunology, BSMMU

Presented by DR. NUSRAT SIDDIQUA Phase B student. Department of Microbiology & Immunology, BSMMU Presented by DR. NUSRAT SIDDIQUA Phase B student Department of Microbiology & Immunology, BSMMU Introduction Agglutination is a laboratory diagnostic test based on the reaction between a particular antigen

More information

IMMUNITY AND DISEASE II

IMMUNITY AND DISEASE II IMMUNITY AND DISEASE II A. Evolution of the immune system. 1. Figure 1--57.25, p. 1167 from Raven and Johnson Biology 6 th ed. shows how the immune system evolved. Figure 1. How the immune system evolved.

More information

Heterologous Treponema pallidum Strains

Heterologous Treponema pallidum Strains INFECTION AND IMMUNITY, Sept. 1984, p. 561-565 0019-9567/84/090561-05$02.00/0 Copyright 1984, American Society for Microbiology Vol. 45, No. 3 Response of Syphilitic Rabbits to Reinfection with Homologous

More information

Immune System. Biol 105 Chapter 13

Immune System. Biol 105 Chapter 13 Immune System Biol 105 Chapter 13 Outline Immune System I. Function of the Immune system II. Barrier Defenses III. Nonspecific Defenses A. Immune system cells B. Inflammatory response C. Complementary

More information

Quantitative Assay of Paravaccinia Virus Based

Quantitative Assay of Paravaccinia Virus Based APPrU MICROBIOLOGY, JUly 1972, p. 138-142 Copyright 1972 American Society for Microbiology Vol. 24, No. 1 Printed in U.S.A. Quantitative Assay of Paravaccinia Virus Based on Enumeration of Inclusion-Containing

More information